Good to Know > Arechar Healthcare introduces an anticancer drug, Sorafina
Arechar Healthcare introduces an anticancer drug, Sorafina
Sorafenib is used for the treatment of certain types of cancer.
Arechar announces the launch of Sorafenib marketed under the brand name Sorafina. It is used to treat a certain type of cancer (liver cancer, kidney cancer, and thyroid cancer). This medication belongs to a class of medication known as a tyrosine kinase inhibitor. It works by slowing or stopping the growth of cancer. Sorafenib is a synthetic compound targeting growth signaling and angiogenesis. Sorafenib blocks the enzyme RAF kinase, a critical component of the RAF/MEK/ERK signaling pathway that controls cell division and proliferation. The manufacturing unit of Arechar Healthcare has provided key features of Sorafina.
Sorafina is the most valuable and promising treatment for hepatocellular carcinoma, kidney cancer, and thyroid cancer. Sorafenib drug is also known as a cancer growth blocker. It stops the cancer cells from forming new blood vessels.
Sorafina (Sorafenib) is a protein kinase inhibitor with activity against many protein kinases, including VEGFR, PDGFR, and RAF kinases.
The molecular formula of Sorafenib is C21H16CIF3N4O3 and the molecular weight is 464.8 g/mol.
“The concerns of patients are our strengths, for they let us remember the need for healthcare and life-saving drugs. To fulfill such demands and requirements, our team works all day, every day, to recover the faith of the patients while rediscovering the hopes of betterment,” said Mr. Harpreet Singh, Founder of Arechar Healthcare.
“Launching a whole new range of life-saving drugs, Arechar Healthcare Team is devoted to making their lives healthier, by introducing affordable and approved medicines in the oncology sector,” said Mrs. Ruchika Rajbans, Co-Founder of Arechar Healthcare. “Our mission is to create more accessible regimens for the betterment of the patients.”
About Arechar Healthcare
Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.
Related hot topics
Bortecine, an effective drug for Blood cancer
Bortecine, for Multiple Myeloma and Mantle Cell Lymphoma
Arechar Healthcare provides independent and precise information about prescription drugs with the related news and press releases. This content is displayed for informational purposes only and is not intended to be an alternative for any medical advice/prescription or treatment. Do not delay or ignore any medical treatment owing to something you’ve read or seen on this website. Also, this website offers links to other websites, enabling the viewers to directly switch to that website for detailed information or accurate references. Thus, Arechar is not responsible for the content displayed on the linked websites or the content of the links in the linked website.